BiotechTube
Home/PulseSight Therapeutics/Judith Greciet, PharmD
JG

Judith Greciet, PharmD

Chief Executive Officer

PulseSight Therapeutics

Therapeutic Areas

OphthalmologyRetinal Diseases

PulseSight Therapeutics Pipeline

DrugIndicationPhase
PST-611Dry AMD / Geographic AtrophyPhase 1
PST-809Wet AMDPhase 1/2

Leadership Team at PulseSight Therapeutics

DS
Dirk Sauer
Independent Chair of the Board
FB
Francine Behar-Cohen, MD, PhD
Observer & Founder
View full PulseSight Therapeutics profile